Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
418K
-
Shares change
-
+109K
-
Total reported value, excl. options
-
$869K
-
Value change
-
+$593K
-
Put/Call ratio
-
0.64
-
Number of buys
-
15
-
Number of sells
-
-1
-
Price
-
$2.08
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q1 2019
18 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q1 2019.
IGC Pharma, Inc. - COM NEW (IGC) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 418K shares
.
Largest 10 shareholders include DEARBORN PARTNERS LLC (103K shares), BANK OF MONTREAL /CAN/ (65K shares), Creative Planning (64K shares), GOLDMAN SACHS GROUP INC (37.4K shares), SUNTRUST BANKS INC (36.7K shares), MORGAN STANLEY (30.2K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (20.8K shares), Cambridge Investment Research Advisors, Inc. (16.5K shares), TWO SIGMA SECURITIES, LLC (14.5K shares), and JANE STREET GROUP, LLC (11K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.